Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Farand

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Analytical Chemistry|May 15, 2009
De novo sequence determination of modified oligonucleotidesJulie Farand, Francis Gosselin
Analytical Chemistry|August 30, 2008
Sequence confirmation of modified oligonucleotides using chemical degradation, electrospray ionization, time-of-flight, and tandem mass spectrometryJulie Farand, Michael Beverly
Bioorganic & Medicinal Chemistry Letters|November 24, 2016
Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potencyJulie Farand, Nicholas Mai, Jayaraman Chandrasekhar, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptorJason D Burch, Julie Farand, John Colucci, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptorJason D Burch, Michel Belley, Réjean Fortin, et al.
Journal of Medicinal Chemistry|February 19, 2010
The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonistMarc Blouin, Yongxin Han, Jason Burch, et al.
Bioconjugate Chemistry|January 14, 2014
Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsivenessErin N Guidry, Julie Farand, Arash Soheili, et al.
Plos One|December 8, 2022
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virusSarah A Gilmore, Danny Tam, Tara L Cheung, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)ValidationJulie Farand, Jeffrey E Kropf, Peter Blomgren, et al.
Journal of Medicinal Chemistry|November 21, 2024
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary FibrosisDoris T Tang, Zhimin Du, Kin S Yang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Analytical Chemistry|May 15, 2009
De novo sequence determination of modified oligonucleotidesJulie Farand, Francis Gosselin
Analytical Chemistry|August 30, 2008
Sequence confirmation of modified oligonucleotides using chemical degradation, electrospray ionization, time-of-flight, and tandem mass spectrometryJulie Farand, Michael Beverly
Bioorganic & Medicinal Chemistry Letters|November 24, 2016
Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potencyJulie Farand, Nicholas Mai, Jayaraman Chandrasekhar, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptorJason D Burch, Julie Farand, John Colucci, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2008
Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptorJason D Burch, Michel Belley, Réjean Fortin, et al.
Journal of Medicinal Chemistry|February 19, 2010
The discovery of 4-{1-[({2,5-dimethyl-4-[4-(trifluoromethyl)benzyl]-3-thienyl}carbonyl)amino]cyclopropyl}benzoic acid (MK-2894), a potent and selective prostaglandin E2 subtype 4 receptor antagonistMarc Blouin, Yongxin Han, Jason Burch, et al.
Bioconjugate Chemistry|January 14, 2014
Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsivenessErin N Guidry, Julie Farand, Arash Soheili, et al.
Plos One|December 8, 2022
Characterization of a KDM5 small molecule inhibitor with antiviral activity against hepatitis B virusSarah A Gilmore, Danny Tam, Tara L Cheung, et al.
ACS Medicinal Chemistry Letters|March 19, 2020
Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)ValidationJulie Farand, Jeffrey E Kropf, Peter Blomgren, et al.
Journal of Medicinal Chemistry|November 21, 2024
Discovery of GS-2278, a Potent and Selective LPAR1 Antagonist for the Treatment of Idiopathic Pulmonary FibrosisDoris T Tang, Zhimin Du, Kin S Yang, et al.
Pageof 1